Company intelligence / Profile preview

ecoNugenics

Santa Rosa, California, USAeconugenics.com ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

ecoNugenics has nearly 200 published studies supporting its physician-formulated nutraceutical blends. Its flagship product, PectaSol-C (modified citrus pectin), is clinically substantiated and supported by over 65 peer-reviewed studies. The company collaborates with leading academic institutions such as Harvard University, NIH, Columbia University Medical Center, and MD Anderson Cancer Center to validate the efficacy of its products in various areas of human wellness.

Therapeutic areas: Metabolic DisordersImmunologyOtherGastroenterologyCardiovascularWomen's Health
Modalities: Small moleculeNatural product
Industry: Food & Nutrition

Drug pipeline

2 assets

PectaSol

Commercial

Indications: Cancer support, Detoxification, Immune support

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with Harvard University Medical School, NIH, Columbia University Medical Center’s Department of Urology, Indiana University Health’s Cancer Research Laboratory, MD Anderson Cancer Clinic

Beyond the preview

Go deeper on ecoNugenics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ecoNugenics.

Explore the full profile